National Health Act 1953 - Amendment determinations under sections 85, 85a and 88 - pharmaceutical benefits (No. PB 93 of 2008) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 93 of 2008

Amendment determinations under sections 85, 85A and 88 of the National Health Act 1953

I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under sections 85, 85A and 88 of the National Health Act 1953.

Dated 1^st SEPTEMBER 2008

DIANA MACDONELL

Acting Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment determination — pharmaceutical benefits

1              Commencement

This instrument commences on 1 October 2008.

2              Amendment of PB 75 of 2008

Schedule 1 amends PB 75 of 2008.

Schedule 1        Amendments

[1]       Part 1 of Schedule 1, item dealing with Amlodipine in the forms Tablet 5 mg (as besylate) and

Tablet 10 mg (as besylate)

in the column headed “Brand” insert in alphabetical order:

Ozlodip

[2]       Part 1 of Schedule 1, item dealing with Amoxycillin

omit from the columns in the order indicated:

Tablet, chewable, 250 mg (as trihydrate) Oral 20 1 Amoxil

[3]       Part 1 of Schedule 1, item dealing with Amoxycillin in the forms Capsule 250 mg (as trihydrate) and

Capsule 500 mg (as trihydrate)

in the column headed “Brand” insert in alphabetical order:

APO-Amoxycillin

[4]       Part 1 of Schedule 1, item dealing with Cisplatin in the form I.V. injection 100 mg in 100 mL

in the column headed “Brand” insert in alphabetical order:

Pfizer Australia Pty Ltd

[5]       Part 1 of Schedule 1, after item dealing with Enoxaparin in the form Injection containing enoxaparin sodium

40 mg (4,000 I.U. anti-Xa) in 0.4 mL pre-filled syringe

insert in the columns in the order indicated:

Solution for injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL Injection 10 1 Clexane

[6]       Part 1 of Schedule 1, item dealing with Fluconazole in the forms Solution for I.V. infusion 100 mg in 50 mL and Solution for I.V. infusion 200 mg in 100 mL

in the column headed “Brand” insert in alphabetical order:

Fluconazole Hexal

[7]       Part 1 of Schedule 1, item dealing with Gabapentin in the form Tablet 600 mg

in the column headed “Brand” insert in alphabetical order:

Gabahexal 600mg

[8]       Part 1 of Schedule 1, item dealing with Lamotrigine in the forms Tablet 25 mg, Tablet 50 mg, Tablet 100 mg and Tablet 200 mg

in the column headed “Brand” insert in alphabetical order:

Lamotrigine Sandoz

[9]       Part 1 of Schedule 1, after item dealing with Paliperidone in the form Tablet 9 mg (prolonged release)

insert in the columns in the order indicated:

Tablet 12 mg (prolonged release) Oral 28 5 Invega

[10]     Part 1 of Schedule 1, item dealing with Pravastatin in the form Tablet containing pravastatin sodium 10 mg

(a) in the column headed “Brand” insert in alphabetical order:

Pravastatin-GA 10

(b) in the column headed “Brand” insert in alphabetical order:

Pravastatin generichealth

[11]     Part 1 of Schedule 1, item dealing with Pravastatin in the form Tablet containing pravastatin sodium 20 mg

(a) in the column headed “Brand” insert in alphabetical order:

Pravastatin-GA 20

(b) in the column headed “Brand” insert in alphabetical order:

Pravastatin generichealth

[12]     Part 1 of Schedule 1, item dealing with Pravastatin in the form Tablet containing pravastatin sodium 40 mg

(a) in the column headed “Brand” insert in alphabetical order:

Pravastatin-GA 40

(b) in the column headed “Brand” insert in alphabetical order:

Pravastatin generichealth

[13]     Part 1 of Schedule 1, item dealing with Pravastatin in the form Tablet containing pravastatin sodium 80 mg

(a) in the column headed “Brand” insert in alphabetical order:

Pravastatin-GA 80

(b) in the column headed “Brand” insert in alphabetical order:

Pravastatin generichealth

[14]     Part 1 of Schedule 1, item dealing with Sertraline in the forms Tablet 50 mg (as hydrochloride) and

Tablet 100 mg (as hydrochloride)

omit from the column headed “Brand”:

Sertraline-DP

and substitute:

Sertraline-GA

[15]     Part 2 of Schedule 1, after item dealing with Enoxaparin in the form Injection containing enoxaparin sodium

40 mg (4,000 I.U. anti-Xa) in 0.4 mL pre-filled syringe

insert in the columns in the order indicated:

Solution for injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL Haemodialysis Injection 20 3 Clexane

[16]     Part 1 of Schedule 3, item dealing with Amoxycillin

omit from the columns in the order indicated:

Tablet, chewable, 250 mg (as trihydrate) Oral 20 . . Amoxil

[17]     Part 1 of Schedule 3, item dealing with Amoxycillin in the forms Capsule 250 mg (as trihydrate) and

Capsule 500 mg (as trihydrate)

in the column headed “Brand” insert in alphabetical order:

APO-Amoxycillin